Protagonist Therapeutics, Inc. Share Price
Stocks
PTGX
US74366E1029
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
After hours 00:56:20 | |||
| 131.42 USD | -4.52% |
|
137.72 | +4.79% |
| Market Cap | 8.45B 7.39B 6.82B 6.3B 11.95B 806B 12.15B 81.47B 32B 397B 31.73B 31.04B 1,365B | P/E 2026 * |
33.6x | P/E 2027 * | -115x |
|---|---|---|---|---|---|
| Enterprise Value | 7.88B 6.89B 6.36B 5.87B 11.14B 751B 11.33B 75.94B 29.82B 370B 29.58B 28.94B 1,272B | EV / Sales 2026 * |
15.4x | EV / Sales 2027 * | 48.5x |
| Free-Float |
97.28% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Protagonist Therapeutics, Inc.
| 1 day | -4.52% | ||
| 1 week | -0.15% | ||
| Current month | +7.21% | ||
| 1 month | +24.25% | ||
| 3 months | +32.99% | ||
| 6 months | +63.82% | ||
| Current year | +50.47% |
| 1 week | 128.15 |  | 141.1 |
| 1 month | 108.53 | | 141.1 |
| Current year | 77 | | 141.1 |
| 1 year | 50.48 | | 141.1 |
| 3 years | 13.72 | | 141.1 |
| 5 years | 6.91 | | 141.1 |
| 10 years | 4.47 | | 141.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 69 | 30/11/2008 |
Asif Ali
DFI | Director of Finance/CFO | 52 | 17/04/2022 |
Venkat Thalladi
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
BRD | Director/Board Member | 69 | 30/11/2008 |
Harold Selick
CHM | Chairman | 71 | 18/03/2014 |
William Waddill
BRD | Director/Board Member | 69 | 30/06/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-22 | Fiscal year | Director | 27,000 | 0.0420% | ||
| 06-09 | Fiscal year | Director | 27,000 | 0.0420% | ||
| 05-28 | Fiscal year | Director | 27,000 | 0.0420% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.52% | -0.15% | +148.78% | +459.71% | 8.45B | |
| +0.58% | +2.06% | +2.92% | +10.86% | 50.73B | |
| -2.22% | -1.25% | +385.40% | +586.81% | 39.73B | |
| -0.54% | +0.39% | +25.57% | -5.28% | 34.69B | |
| -1.36% | +0.35% | +17.88% | +55.14% | 33.21B | |
| +1.21% | -4.58% | +3.00% | +35.46% | 26.76B | |
| -1.81% | -1.48% | - | - | 16.8B | |
| +0.51% | -3.47% | +63.97% | +122.60% | 15.37B | |
| +0.23% | -0.58% | +13.76% | +21.11% | 13.78B | |
| -0.62% | -3.09% | +10.29% | -31.35% | 12.85B | |
| Average | -0.85% | -0.76% | +74.62% | +139.45% | 25.24B | |
| Weighted average by Cap. | -0.62% | -0.23% | +83.14% | +136.35% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 510M 446M 412M 380M 721M 48.65B 733M 4.92B 1.93B 23.97B 1.92B 1.87B 82.4B | 163M 142M 131M 121M 230M 15.52B 234M 1.57B 616M 7.64B 611M 598M 26.28B |
| Net income | 259M 227M 209M 193M 367M 24.74B 373M 2.5B 982M 12.19B 974M 953M 41.9B | -82.92M -72.53M -66.9M -61.79M -117M -7.91B -119M -799M -314M -3.9B -311M -305M -13.39B |
| Net Debt | -574M -502M -463M -428M -811M -54.74B -825M -5.53B -2.17B -26.97B -2.15B -2.11B -92.7B | -565M -494M -456M -421M -798M -53.86B -812M -5.44B -2.14B -26.53B -2.12B -2.07B -91.22B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | US$131.42 | -4.52% | 1,060,849 |
| 09/07/26 | US$137.64 | -1.73% | 1,613,332 |
| 08/07/26 | US$140.07 | -0.55% | 931,358 |
| 07/07/26 | US$140.85 | +7.11% | 1,374,383 |
| 06/07/26 | US$131.50 | -0.09% | 640,087 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PTGX Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition